Opendata, web and dolomites

His-Li mouse

His-Li mouse, the unique humanized mouse model resembling human liver and immune systems

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 His-Li mouse project word cloud

Explore the words cloud of the His-Li mouse project. It provides you a very rough idea of what is the project "His-Li mouse" about.

save    first    rate    pharmaceuticals    faster    perform    supply    breakthrough    optimise    reflects    liver    prospect    strikingly    eliminate    single    mice    excretion    humanization    unnecessary    market    reduce    toxic    service    adme    mouse    trials    deadly    accounting    models    experimental    customers    sound    critical    plans    clinical    efficacy    metabolism    transcure    reaching    quality    costly    perfectly    70    generation    humanized    bioservices    evaluation    approved    least    accurate    programs       toxicology    subsequently    lack    validate    iterations    preclinical    validation    model    innovation    safe    tests    lies    combination    tool    immune    humans    physiology    fail    benefit    fact    potentially    chain    drug    unexpected    drugs    population    li    toxicity    efficient    unpredictably    21    millions       total    discovery    reveal    protocol    13    feasibility    global    offers    strategy    human    safety    pharmaceutical    lives    reflect    absorption    representing   

Project "His-Li mouse" data sheet

The following table provides information about the project.

Coordinator
TRANSCURE BIOSERVICES SAS 

Organization address
address: BIOPARK LE FORUM 1 260 AVENUE MARI
city: ARACHAMPS
postcode: 74160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website https://www.transcurebioservices.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TRANSCURE BIOSERVICES SAS FR (ARACHAMPS) coordinator 50˙000.00

Map

 Project objective

Preclinical toxicology evaluation is the most critical step in pharmaceutical drug development, representing about 21.2% of the total drug development costs. About 70% of drug development programs fail due to toxicity or unexpected issues in Absorption, Distribution, Metabolism, and Excretion (ADME) at Phase 1 validation on humans. The main problem lies on the lack of accurate and reliable pre-clinical mouse models: in fact, current models fail to reflect human liver physiology, and often lead to the development of drugs that are safe in mice, and reveal unpredictably toxic or even deadly in humans. Strikingly, only 13.8% of drugs development programs are finally approved. The development of a single drug requires at least 1,000 iterations, accounting for about €10 M in total, and procedures that can take up to 10 years. TransCure bioServices offers the His-Li-mouse, a humanized mouse model for pre-clinical drug testing, based on the unique combination of the humanized liver and immune systems. His-Li-mouse is the first pre-clinical model that perfectly reflects the human liver physiology and immune response, thus representing a unique tool to perform reliable pre-clinical safety and efficacy tests of drugs. His-Li-mouse enables to reduce the failure rate observed when reaching the clinical trials and to subsequently eliminate unnecessary and costly experimental iterations. This will benefit to the global population, as a more efficient drug development process will potentially save millions of lives or improve its quality by enabling the faster discovery of breakthrough pharmaceuticals. During the phase 1 feasibility study, TransCure will establish a sound go-to-market strategy and supply chain, and will draft further development plans. During the innovation project, TransCure will optimise the humanization protocol, scale-up mice generation and validate the His-Li-mouse pre-clinical service with prospect customers.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HIS-LI MOUSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HIS-LI MOUSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IMPACT (2019)

Improving DNA Analysis for Correct Healthcare

Read More  

TankSensor (2020)

Smart monitoring solution for better procurement and supply chain management - Speeding up chemical industry digitalization

Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More